Havens Advisors’s ChemoCentryx CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-75,000
Closed -$3.88M – 45
2022
Q3
$3.88M Buy
+75,000
New +$3.1M 5.8% 2

Other funds holding CCXI

Havens Advisors's CCXI Position: Q4 2022 in Review

Havens Advisors sold out of ChemoCentryx (CCXI) in Q4 2022, closing a stake of 75,000 shares — an estimated $3.88M sold.

Havens Advisors first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $3.88M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Havens Advisors reported no remaining ChemoCentryx position as of Q4 2022 after selling out during the quarter.
  • Havens Advisors sold 75,000 ChemoCentryx shares in Q4 2022, an estimated $3.88M.
  • Havens Advisors first reported a position in ChemoCentryx in Q3 2022 and held it in 1 quarter.
  • Havens Advisors's ChemoCentryx position peaked at $3.88M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx as of Q4 2022.

Based on Havens Advisors's 13F filing for Q4 2022, filed 25 Jan 2023.